The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
Clinical trial NCT04792580 · COMPLETED
Trial details
- NCT number
- NCT04792580
- Sponsor
- Richard W Yee, MD
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-22
- Primary completion
- 2024-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.